A genetically modified adenoviral vector with a phage display-derived peptide incorporated into fiber fibritin chimera prolongs survival in experimental glioma

Authors

Julius W. Kim, University of Chicago
J. Robert Kane, University of Chicago
Jacob S. Young, University of Chicago
Alan L. Chang, University of Chicago
Deepak Kanojia, University of Chicago
Ramin A. Morshed, University of Chicago
Jason Miska, University of Chicago
Atique U. Ahmed, University of Chicago
Irina V. Balyasnikova, University of Chicago
Yu Han, University of Chicago
Lingjiao Zhang, University of Chicago
David T. Curiel, Washington University School of Medicine
Maciej S. Lesniak, University of Chicago

Journal

Human Gene Therapy

Publication Date

2015

Volume

26

Issue

9

Inclusive Pages

635-646

Document Type

Open Access Publication

Rights and Permissions

This is a copy of an article published in the Human Gene Therapy © 2015 © Mary Ann Liebert, Inc.; Human Gene Therapy is available online at: http://online.liebertpub.com.

Recommended Citation

Kim, Julius W.; Kane, J. Robert; Young, Jacob S.; Chang, Alan L.; Kanojia, Deepak; Morshed, Ramin A.; Miska, Jason; Ahmed, Atique U.; Balyasnikova, Irina V.; Han, Yu; Zhang, Lingjiao; Curiel, David T.; and Lesniak, Maciej S., "A genetically modified adenoviral vector with a phage display-derived peptide incorporated into fiber fibritin chimera prolongs survival in experimental glioma." Human Gene Therapy. 26, 9. 635-646. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/4698